2022 annual financial data
Dianthus Therapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -453.02%.
Operating income was -29,705,000 USD and net income was -28,476,000 USD.
Operating cash flow was -29,070,000 USD.
Get free Dianthus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,417,000 USD
- Operating income
- -29,705,000 USD
- Net income
- -28,476,000 USD
- Operating cash flow
- -29,070,000 USD